Scorpius Holdings Announces Reverse Stock Split

Core Points - Scorpius Holdings, Inc. approved a 1-for-200 reverse stock split to increase the selling price of its common stock and regain compliance with NYSE American requirements [2][3] - The reverse stock split will take legal effect at 11:01 P.M. Eastern Time on July 17, 2024, with trading on a post-split basis commencing on July 18, 2024 [7] - The ownership percentage of each stockholder will remain unchanged, except for fractional shares [2] Company Overview - Scorpius Holdings, Inc. is an integrated contract development and manufacturing organization (CDMO) focused on advancing biologic and cell therapy programs [8] - The company provides a wide range of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas [8] - Scorpius emphasizes transparent collaboration and high-quality biologics biomanufacturing [8]